Zymeworks Added to Nasdaq Biotechnology Index
December 15, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...
Zymeworks Announces Participation in Upcoming Investor Conference
November 30, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 07, 2023 16:05 ET
|
Zymeworks Inc.
Net loss for the first nine months of 2023 decreased by 44% as compared to the same period in 2022Cash resources of $390.2 million as of September 30, 2023 expected to fund planned operations through...
Zymeworks Announces Participation in Upcoming Investor Conferences
November 01, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...
Zymeworks To Host Third Quarter 2023 Results Conference Call
October 17, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...
Zymeworks Announces New Director Nominee
October 16, 2023 16:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel multifunctional biotherapeutics, today announced...
Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 10, 2023 16:05 ET
|
Zymeworks Inc.
Net loss for the first six months of 2023 decreased by 45% as compared to the same period in 2022Cash resources of $431.4 million as of June 30, 2023 expected to fund planned operations through at...
Zymeworks Announces Participation in Upcoming Investor Conferences
August 01, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...
Zymeworks To Host Second Quarter 2023 Results Conference Call
July 19, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...
Zymeworks Announces Participation in Upcoming Investor Conference
July 03, 2023 08:30 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, July 03, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today...